thalidomide has been researched along with medroxyprogesterone acetate in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fowler, R; Imrie, K | 1 |
A'Hern, R; Beirne, DA; Eisen, T; Gore, ME; Hancock, BW; James, MG; Lee, CP; Mak, I; Patel, PM; Pyle, L; Selby, PJ; Steeds, S | 1 |
1 trial(s) available for thalidomide and medroxyprogesterone acetate
Article | Year |
---|---|
Randomized phase II study comparing thalidomide with medroxyprogesterone acetate in patients with metastatic renal cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Carcinoma, Renal Cell; Disease Progression; Female; Humans; Kidney Neoplasms; Life Tables; Male; Medroxyprogesterone Acetate; Middle Aged; Survival Analysis; Thalidomide; Time Factors; Treatment Failure | 2006 |
2 other study(ies) available for thalidomide and medroxyprogesterone acetate
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Thalidomide-associated hepatitis: a case report.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemical and Drug Induced Liver Injury; Dexamethasone; Doxorubicin; Estrogens, Conjugated (USP); Fatal Outcome; Female; Hepatitis C; Humans; Leukemia, Plasma Cell; Medroxyprogesterone Acetate; Megestrol Acetate; Middle Aged; Salvage Therapy; Thalidomide; Thrombocytopenia; Vincristine | 2001 |